Table I.
Group | TC | TG | HDL-C | LDL-C |
---|---|---|---|---|
Blank control | 0.87±0.04 | 0.39±0.06 | 1.19±0.18 | 0.78±0.16 |
Vehicle | 2.64±0.12a | 1.73±0.08a | 0.36±0.04a | 1.42±0.07a |
Positive control | 1.45±0.07b | 0.87±0.04b | 0.89±0.08c | 0.82±0.03b |
hZGJTJY | 1.85±0.02b | 1.25±0.07b | 0.74±0.06c | 0.94±0.06b |
mZGJTJY | 2.27±0.06 | 1.57±0.12 | 0.51±0.09b | 1.21±0.02 |
lZGJTJY | 2.36±0.15 | 1.59±0.05 | 0.49±0.03 | 1.29±0.12 |
P<0.05, compared with the blank control group;
P<0.05 and
P<0.01, compared with the model group.
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; hZGJTJY, high dose Zuo-gui Jiang-tang Jie-yu formulation; mZGJTJY, medium dose Zuo-gui Jiang-tang Jie-yu formulation; lZGJTJY, low dose Zuo-gui Jiang-tang Jie-yu formulation.